Skip to content
Clinical Trial Events
BIO-Europe 2026

Panel Industry Voices track

Women’s Health at an Inflection Point: Redefining Treatment, Regulatory Pathways and Access

Tue, Nov 10, 2026 · 12:20–1:00 PM CET Industry Voices Stage, Koelnmesse

About this session

The discussion will explore how the women’s health treatment landscape is shifting across several fronts — including scientific advances toward non-hormonal, targeted and potentially disease-modifying therapies; evolving regulatory and payer pathways; and changes in disease nomenclature and classification that better reflect underlying biology. The goal is to bring together scientific, clinical and regulatory perspectives to examine the latest signals and where the field is headed.

Speakers

  • Karen Chan

    Senior Director, Lilly Gateway Labs · Eli Lilly and Company

    Moderator

  • Kelle Moley

    VP, Women's Health and Early Clinical Development · Eli Lilly and Company

    Panelist

  • Anouk Petersen

    Partner · McKinsey & Company

    Panelist

  • Stasa Stankovic

    Co-founder & CEO · OvartiX

    Panelist

  • Stephane Thiroloix

    CEO · Apikal Therapeutics

    Panelist

  • Lea Wenger

    CEO and Co-Founder · Cyclana Bio

    Panelist